Plantar Fibroma: Diagnosis and Treatment of Foot Arch Nodules

Quick answer: Treatment for plantar fibroma diagnosis treatment foot arch nodules follows a stepwise approach: 1) conservative care first (rest, ice, supportive footwear, OTC anti-inflammatories), 2) physical therapy and targeted exercises, 3) in-office treatments (injections, custom orthotics) if conservative fails at 4-6 weeks, 4) surgery for refractory cases. Most patients resolve at step 1 or 2. Call (810) 206-1402.

Quick answer: Plantar fascial fibromatosis (Ledderhose disease) is benign nodular thickening on the plantar fascia. Most are painless but cause shoe pressure pain. Treatment: stiff custom orthotic with cutout, soft cushioned shoes, ESWT (shockwave), and verapamil cream. Surgery is last resort due to high recurrence (50-70%). Most patients manage with offloading. — Dr. Tom Biernacki, DPM, board-certified podiatrist (Michigan Foot Doctors).

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatrist, Balance Foot & Ankle Specialists — Updated April 2026

Table of Contents

• What Is a Plantar Fibroma?
• Plantar Fibroma vs. Plantar Fasciitis: Key Differences
• Causes and Risk Factors
• Signs and Symptoms
• How Is a Plantar Fibroma Diagnosed?
• Conservative Treatment Options
• Orthotic Offloading Strategies
• Corticosteroid Injections for Plantar Fibroma
• Verapamil Topical Therapy
• Extracorporeal Shockwave Therapy
• Surgical Excision: When Conservative Care Fails
• Recurrence Rates After Surgery
• Plantar Fibromatosis (Ledderhose Disease)
• Living With a Plantar Fibroma Long-Term
• PowerStep Arch Support for Fibroma Offloading
• Doctor Hoy’s for Plantar Fibroma Pain Relief
• DASS Compression for Post-Treatment Recovery
• Complete Plantar Fibroma Management Kit
• Most Common Mistake
• Warning Signs
• Frequently Asked Questions
• Sources & References
• Video Guide
• Schedule Your Evaluation
• Related Guides

If you’ve discovered a firm, rubbery lump in the arch of your foot, you’re likely dealing with one of the most misunderstood foot conditions we see at Balance Foot & Ankle. Plantar fibromas affect approximately 2-3% of the population, yet many patients suffer for months or years before seeking evaluation — either because they assume it’s “just a callus” or because they’ve been told nothing can be done. Neither is true, and the approach you take in the early stages significantly impacts your long-term outcome.

What Is a Plantar Fibroma?

A plantar fibroma is a benign (non-cancerous) fibrotic mass that develops within the plantar fascia — the thick band of connective tissue running along the bottom of your foot from heel to toes. Unlike a cyst or ganglion, which contains fluid, a plantar fibroma is composed of dense, collagen-rich fibrous tissue that becomes firmly embedded within the fascial structure itself. This is why they feel hard and immovable when you press on them — they’re literally woven into the architecture of your plantar fascia.

These nodules typically range from 1-2 centimeters in diameter, though untreated fibromas can grow larger over months to years. They most commonly appear in the medial (inner) band of the plantar fascia, centered in the highest point of your arch. While a single nodule is called a plantar fibroma, multiple nodules developing across the plantar fascia indicate plantar fibromatosis (also known as Ledderhose disease), a more aggressive form that requires different management strategies.

The critical distinction patients need to understand is that plantar fibromas are benign tumors — not cancer. However, “benign” doesn’t mean “harmless.” These growths create focal pressure points against the ground with every step, progressively irritating surrounding tissue, compressing small nerves in the arch, and altering your gait mechanics as you subconsciously shift weight away from the painful nodule. This compensation pattern creates secondary problems in the ankle, knee, hip, and lower back over time.

Plantar Fibroma vs. Plantar Fasciitis: Understanding the Difference

Patients frequently confuse plantar fibromas with plantar fasciitis because both involve the plantar fascia and cause arch or foot pain. However, these are fundamentally different conditions requiring different treatment approaches. Plantar fasciitis is an overuse injury characterized by inflammation and microtearing at the fascial insertion point on the heel bone — it produces classic heel pain with the first steps in the morning that improves with walking. A plantar fibroma is a growth condition where abnormal fibroblast proliferation creates a structural mass within the fascia itself.

The location and character of pain differs significantly. Plantar fasciitis concentrates pain at the heel, particularly the medial calcaneal tubercle where the fascia attaches. Plantar fibroma pain localizes to the arch where the nodule sits, with a distinct “stepping on a marble” sensation. Plantar fasciitis pain typically worsens after rest and improves with activity, while fibroma pain intensifies with prolonged weight-bearing and pressure — tight shoes and barefoot walking on hard surfaces are particularly aggravating.

It’s also possible — and not uncommon — to have both conditions simultaneously. The altered biomechanics caused by a plantar fibroma can overstress the fascial insertion, triggering secondary plantar fasciitis. When both conditions coexist, treatment must address each component separately, which is why accurate diagnosis through physical examination and imaging is essential before starting any treatment plan.

What Causes Plantar Fibromas? Risk Factors and Associations

The exact cause of plantar fibromas remains incompletely understood, but research has identified several strong associations. The condition appears to have a significant genetic component — plantar fibromatosis runs in families and is strongly associated with other fibroproliferative conditions including Dupuytren’s contracture (fibromas in the palm), Peyronie’s disease, and keloid scarring. Northern European ancestry carries a higher predisposition, particularly Scandinavian and Celtic backgrounds.

Trauma to the plantar fascia may trigger fibroma development in genetically susceptible individuals. Repetitive microtrauma from high-impact activities, direct injuries to the arch, and even chronic fascial strain from biomechanical imbalances have been implicated. Some researchers propose that the body’s wound-healing response goes into overdrive in these patients, producing excessive collagen and fibroblast proliferation instead of normal tissue repair.

Additional risk factors include chronic liver disease (particularly alcoholic liver disease and hepatitis), diabetes mellitus, epilepsy medications (specifically phenytoin/Dilantin), chronic alcohol use, and thyroid disorders. The connection between liver disease and plantar fibromatosis is particularly notable — the altered growth factor metabolism associated with hepatic dysfunction appears to promote fibroproliferative conditions throughout the body. Age is also a factor, with peak incidence occurring between ages 40 and 70, though we see fibromas in younger patients regularly at our practice.

Signs and Symptoms of Plantar Fibroma

The hallmark symptom of a plantar fibroma is a firm, palpable nodule in the arch of the foot that causes pain with direct pressure. Most patients describe the sensation as “stepping on a pebble” or “having a marble stuck under the skin.” The pain intensifies with barefoot walking on hard surfaces, prolonged standing, and wearing shoes with thin or flat soles that don’t cushion the arch. Interestingly, some plantar fibromas are discovered incidentally during routine foot exams — they can exist without causing symptoms if they’re small enough or positioned away from weight-bearing areas.

As the fibroma grows, symptoms typically progress from intermittent discomfort to constant awareness of the mass. Pain may radiate along the arch in both directions as the enlarging nodule compresses adjacent lateral plantar nerve branches. Some patients develop numbness or tingling in the toes if the fibroma encroaches on nerve pathways. The overlying skin usually appears normal without discoloration or warmth, distinguishing fibromas from inflammatory conditions or infections.

Bilateral fibromas (nodules in both feet) occur in approximately 25-33% of patients, which supports the systemic/genetic component of the disease rather than a purely local mechanical cause. If you discover a nodule in one arch, it’s worth having the other foot examined as well. Multiple nodules in the same foot suggest plantar fibromatosis rather than an isolated fibroma, and this distinction affects prognosis and treatment planning significantly.

How Is a Plantar Fibroma Diagnosed?

Diagnosis begins with a thorough clinical examination. A plantar fibroma has distinctive physical findings — a firm, non-mobile mass embedded within the plantar fascia that does not transilluminate (ruling out fluid-filled cysts) and moves with the fascia during dorsiflexion of the toes. The “windlass test” is particularly useful: when the examiner dorsiflexes the great toe, the plantar fascia tightens, and the fibroma becomes more prominent and easier to palpate. This maneuver also reproduces the patient’s characteristic arch pain.

Diagnostic ultrasound is our primary imaging modality at Balance Foot & Ankle for plantar fibromas. Ultrasound clearly delineates the fibroma’s size, depth, location within the fascial layers, and relationship to adjacent structures — all critical information for treatment planning. Fibromas appear as well-defined, hypoechoic (dark) masses within the plantar fascia with distinct borders. Ultrasound is performed in-office, provides immediate results, involves no radiation, and can be repeated serially to monitor growth over time.

MRI may be indicated for larger masses, atypical presentations, or when surgical planning requires detailed soft tissue mapping. MRI provides superior contrast resolution and can differentiate fibromas from other soft tissue masses including giant cell tumors, synovial sarcomas, and nerve sheath tumors. Biopsy is rarely necessary for typical presentations but may be recommended if the mass has atypical imaging characteristics, is growing rapidly, or shows features suggesting malignancy — which is exceedingly rare in the plantar fascia.

Conservative Treatment Options for Plantar Fibroma

Conservative management is the recommended first-line approach for plantar fibromas, particularly given the high recurrence rates associated with surgical excision. The goal of conservative treatment is not to eliminate the fibroma — non-surgical methods rarely achieve complete resolution — but rather to minimize pain, prevent growth, and maintain functional mobility. A multi-modal approach combining offloading, anti-inflammatory measures, and activity modification typically achieves the best outcomes.

Footwear modification forms the foundation of conservative management. Shoes with adequate arch support, cushioned midsoles, and sufficient depth to accommodate orthotic inserts reduce direct pressure on the fibroma during weight-bearing. Avoid thin-soled shoes, flip-flops, and going barefoot on hard surfaces — each of these scenarios maximizes ground reaction force directly against the nodule. Athletic shoes with rocker-bottom soles can be particularly effective because they reduce plantar pressure during the propulsive phase of gait when arch loading peaks.

Padding and accommodative modifications provide immediate symptomatic relief. A U-shaped or donut-shaped felt pad positioned around (not over) the fibroma redistributes weight-bearing forces away from the nodule. Custom orthotics with a fibroma accommodation — essentially a depression carved into the orthotic at the exact location of the mass — are the gold standard for long-term offloading. These are fundamentally different from standard arch-support orthotics, which would actually increase pressure on the fibroma by pushing up into the arch.

Orthotic Offloading Strategies for Plantar Fibroma

Effective orthotic management of plantar fibromas requires a fundamentally different approach than standard orthotic prescriptions. While most foot conditions benefit from increased arch support, a plantar fibroma sitting within the arch demands accommodation — creating space for the nodule rather than pressing against it. The ideal orthotic for fibroma patients features a total-contact shell with a precisely mapped depression at the fibroma site, surrounded by supportive contouring that maintains biomechanical control everywhere else.

At Balance Foot & Ankle, we use digital pressure mapping alongside clinical palpation to identify the exact fibroma footprint for orthotic accommodation. The accommodation must be deep enough to eliminate direct pressure but not so large that it destabilizes the overall support structure. Getting this balance right requires expertise — an accommodation that’s too wide creates a “hammock effect” where the foot collapses into the void, potentially worsening symptoms. This is why over-the-counter arch supports often fail fibroma patients and sometimes make them worse.

Corticosteroid Injections for Plantar Fibroma

Corticosteroid injections are a commonly employed treatment for plantar fibromas, though their role is primarily palliative rather than curative. Injecting a corticosteroid (typically dexamethasone or triamcinolone) directly into or adjacent to the fibroma reduces inflammation in surrounding tissues and can temporarily soften and shrink the mass. Studies show approximately 50-70% of patients experience meaningful pain reduction following a corticosteroid injection series, though the effect duration varies from weeks to months.

The mechanism of steroid-induced fibroma shrinkage appears to involve suppression of fibroblast proliferation and collagen synthesis, along with promotion of collagen degradation within the mass. However, this effect is dose-limited — repeated high-dose steroid injections into the plantar fascia carry risks including fascial rupture, fat pad atrophy, skin depigmentation, and paradoxical tissue weakening. We typically limit corticosteroid injections to 2-3 sessions spaced 6-8 weeks apart, using ultrasound guidance to ensure precise delivery into the fibroma capsule rather than surrounding healthy tissue.

Some practitioners combine corticosteroid injection with needling — using the injection needle to mechanically disrupt the fibroma’s collagen architecture before depositing the medication. This technique, sometimes called “intralesional needling with steroid,” may enhance the steroid’s fibrolytic effect by creating channels within the dense mass that improve medication penetration. Early results are promising but long-term studies are still limited.

Verapamil Topical Therapy for Plantar Fibromatosis

Topical verapamil (a calcium channel blocker) has emerged as an off-label treatment option for plantar fibromatosis based on its documented anti-fibrotic properties. Applied as a 15% compounded gel directly to the skin overlying the fibroma, verapamil inhibits fibroblast proliferation, reduces collagen production, and promotes collagen breakdown through increased collagenase activity. Clinical studies report fibroma softening and size reduction in 50-65% of patients after 6-12 months of consistent application.

The treatment protocol typically involves applying verapamil gel to the fibroma site twice daily under occlusive dressing for maximum skin penetration. Transdermal delivery to the deep plantar fascia remains the primary limitation — the thick plantar skin and subcutaneous tissue present a significant barrier. Some protocols enhance penetration using iontophoresis (electrical current-driven delivery) or phonophoresis (ultrasound-driven delivery), which may improve outcomes over topical application alone.

Verapamil therapy requires patience — meaningful results typically take 3-6 months to manifest, and the treatment course extends 9-12 months for maximum effect. This extended timeline frustrates many patients, but the favorable side-effect profile (minimal systemic absorption, occasional local skin irritation) makes it a reasonable option for patients who want to avoid steroid injections or surgery. Insurance coverage for compounded verapamil gel varies significantly — many patients pay out-of-pocket costs ranging from $50-$150 per month.

Extracorporeal Shockwave Therapy for Plantar Fibroma

Extracorporeal shockwave therapy (ESWT) delivers focused acoustic energy waves to the fibroma, creating controlled microtrauma that stimulates remodeling of the fibrotic tissue. While ESWT is well-established for plantar fasciitis and other tendinopathies, its application to plantar fibromas is more recent and evidence is still accumulating. Preliminary studies show promising results — shockwave therapy appears to reduce fibroma size and pain scores in approximately 60-70% of treated patients, with effects that may be more durable than corticosteroid injections.

The proposed mechanism involves disruption of the dense collagen matrix within the fibroma, triggering an inflammatory cascade that recruits normal healing pathways instead of the aberrant fibroproliferative response that created the mass originally. Additionally, ESWT appears to reduce substance P concentrations in treated tissue, providing analgesic effects independent of structural changes. Treatment protocols typically involve 3-5 sessions performed weekly, with each session delivering 2,000-3,000 impulses at medium to high energy density.

At Balance Foot & Ankle, we offer ESWT as part of a comprehensive fibroma management plan rather than a standalone treatment. Combined with orthotic offloading, topical therapies, and activity modification, shockwave therapy addresses the pain and structural components simultaneously. Patients who respond best tend to have fibromas smaller than 2 cm, symptom duration less than 2 years, and no prior surgical intervention — suggesting that earlier treatment produces better outcomes with this modality.

Surgical Excision: When Conservative Care Fails

Surgical removal becomes a consideration when 6-12 months of comprehensive conservative treatment fails to provide adequate pain relief and the fibroma significantly impairs daily function. Surgery for plantar fibromas ranges from simple local excision (removing only the nodule) to wide fascial excision (removing the fibroma plus a margin of surrounding plantar fascia) to complete fasciectomy (removing the entire plantar fascia). The extent of surgery directly correlates with both the recurrence rate and the functional recovery period.

Local excision — simply “shelling out” the nodule — is the least invasive surgical approach but carries the highest recurrence rate, reported between 60-100% in various studies. This high rate occurs because fibroma cells infiltrate microscopically beyond the visible mass border, and leaving even a small number of abnormal fibroblasts behind provides a nidus for regrowth. Wide excision with 2-3 cm margins significantly reduces recurrence (20-40%) but creates a larger fascial defect that requires longer healing and may alter foot biomechanics permanently.

Complete plantar fasciectomy achieves the lowest recurrence rates (around 10-25%) but carries significant consequences including arch collapse, chronic plantar pain, lateral foot overloading, and a prolonged recovery period of 3-6 months. This aggressive approach is generally reserved for extensive plantar fibromatosis (Ledderhose disease) that has failed all other treatments. At Balance Foot & Ankle, we have detailed conversations about these tradeoffs with every surgical candidate — understanding that even successful surgery may exchange one problem for different ones is essential for informed decision-making.

Understanding Recurrence Rates After Fibroma Surgery

The high recurrence rate is the defining challenge of plantar fibroma surgery and the primary reason conservative management remains preferred when possible. Recurrence occurs because plantar fibromatosis is fundamentally a systemic fibroproliferative tendency expressing locally in the foot — removing the mass doesn’t address the underlying biological predisposition that created it. Patients with Dupuytren’s contracture, family history of fibromatosis, or bilateral foot involvement are at particularly high risk for post-surgical recurrence.

Adjuvant radiation therapy following surgical excision has shown promise in reducing recurrence rates. Low-dose radiotherapy (typically 30 Gy delivered in 10 fractions over 2 weeks) targets residual fibroblasts at the surgical margin and inhibits their proliferative capacity. European studies report recurrence rates as low as 10-15% when radiation is combined with wide excision, compared to 40-60% with surgery alone. However, radiation therapy carries its own risks including skin changes, potential long-term tissue effects, and theoretical (though very low) secondary malignancy risk.

When recurrence does occur, it typically manifests within 1-3 years after surgery, often presenting as multiple nodules rather than a single mass — the surgical disruption appears to scatter fibroblasts that then seed new growth sites. Revision surgery for recurrent fibromas is technically more challenging due to scar tissue, altered anatomy, and often larger disease extent. This is why we exhaust all conservative options before recommending surgery and ensure every patient fully understands the recurrence statistics before proceeding.

Plantar Fibromatosis (Ledderhose Disease): When Multiple Nodules Develop

Plantar fibromatosis, also known as Ledderhose disease (named after German surgeon Georg Ledderhose who first described it in 1894), represents the more aggressive end of the plantar fibroma spectrum. Rather than a single isolated nodule, Ledderhose disease involves multiple fibrous nodules or cord-like bands developing across the plantar fascia, often progressively over years. The condition is the foot equivalent of Dupuytren’s contracture in the hand, and the two conditions share genetic risk factors, histological features, and treatment challenges.

Ledderhose disease tends to be more symptomatic than isolated fibromas because the multiple nodules and fascial thickening create broader areas of pressure sensitivity and greater biomechanical disruption. In advanced cases, the fibrotic bands can cause toe contractures similar to the finger contractures seen in Dupuytren’s disease, though this progression is less common in the foot. The bilateral involvement rate in Ledderhose disease approaches 50%, and approximately 25% of Ledderhose patients will also have or develop Dupuytren’s contracture.

Management of Ledderhose disease requires a more comprehensive and aggressive conservative approach than isolated fibromas. Custom orthotics must accommodate multiple nodules simultaneously, injection protocols may need to address several sites, and the threshold for considering surgical intervention is higher due to the increased recurrence risk in multi-nodular disease. Radiation therapy has shown particular promise for Ledderhose disease when initiated early — treating nodules while they’re still small and few in number appears to slow or halt disease progression in approximately 80% of cases.

Living With a Plantar Fibroma Long-Term

Many patients with plantar fibromas manage their condition successfully for years with conservative measures, and this is actually the expected outcome rather than a treatment failure. Since fibromas are benign and carry no malignant transformation risk, living with a well-managed fibroma is a perfectly reasonable and often preferable alternative to surgery with its attendant recurrence risk and recovery demands. The key is establishing an effective management routine early and maintaining it consistently.

Long-term management revolves around three pillars: consistent orthotic use, appropriate footwear, and periodic monitoring. Custom orthotics with fibroma accommodation should be worn during all weight-bearing activities — patients who wear their orthotics intermittently tend to experience symptom flares during unprotected walking that can take days to settle. Orthotics should be replaced annually or when the accommodation loses its defined shape, as compressed orthotics gradually lose their offloading effectiveness and reintroduce pressure against the nodule.

Annual monitoring through clinical examination and periodic ultrasound imaging allows tracking of fibroma size, detection of new nodules, and early identification of any changes that might warrant treatment adjustment. Most fibromas reach a growth plateau within 1-3 years and remain stable thereafter, though growth spurts can occur with changes in activity level, hormonal fluctuations, or other systemic triggers. Documenting the baseline size and monitoring for changes provides objective data for treatment decisions rather than relying solely on subjective symptom reports.

PowerStep Arch Support for Fibroma Offloading

For patients with smaller fibromas (under 1.5 cm) that cause mild to moderate symptoms, PowerStep insoles combined with a donut pad applied directly to the insole around the fibroma location can provide surprisingly effective relief. This combination costs a fraction of custom orthotics and can be implemented immediately. If this approach provides adequate symptom control, it may be all that’s needed — we always start with the least expensive effective treatment and escalate only when necessary.

Doctor Hoy’s Natural Pain Relief for Plantar Fibroma Discomfort

Plantar fibroma pain involves both direct pressure sensitivity and surrounding soft tissue inflammation, making topical analgesics a valuable complement to mechanical offloading. Doctor Hoy’s Natural Pain Relief Gel combines arnica’s anti-inflammatory properties with menthol’s analgesic cooling effect, targeting both components of fibroma discomfort without the systemic effects of oral NSAIDs that many patients take daily for arch pain.

Apply Doctor Hoy’s gel directly to the arch over the fibroma location before bed and after prolonged weight-bearing activities when inflammation peaks. The menthol provides immediate sensory relief by activating TRPM8 cold receptors that effectively “gate” pain signals from the fibroma, while arnica works on the inflammatory component over hours. This topical approach is particularly valuable for patients who can’t tolerate oral anti-inflammatories due to gastrointestinal, renal, or cardiovascular contraindications.

Many of our fibroma patients develop a morning application routine — applying Doctor Hoy’s roll-on to the arch before putting on socks and orthotics creates a pre-emptive comfort layer that reduces pain buildup throughout the day. The clean, natural formulation doesn’t stain orthotics or leave residue on insoles, making it compatible with daily orthotic use. Combined with proper offloading, this topical routine often reduces patients’ reliance on oral pain medications significantly.

DASS Compression Socks for Post-Treatment Recovery

Graduated compression plays an important role in plantar fibroma management, particularly during post-injection recovery and for patients with concurrent edema that exacerbates fibroma symptoms. DASS compression socks provide gentle graduated compression that reduces tissue swelling around the fibroma, potentially decreasing the effective size of the symptomatic area by minimizing the inflammatory halo that surrounds the fibrotic mass.

After corticosteroid injections, local tissue swelling and bruising are common for 48-72 hours. DASS compression socks worn during this recovery window minimize post-injection edema and help distribute the injected medication more evenly within the treatment area. The graduated compression also reduces the throbbing sensation many patients experience in the first 24 hours after injection as the local anesthetic wears off and the steroid begins its inflammatory suppression effect.

For patients considering or recovering from surgical excision, DASS graduated compression socks support post-operative healing by maintaining venous return during the immobilization period and reducing surgical site swelling once weight-bearing resumes. The seamless toe construction prevents friction on healing incisions, and the moisture-wicking fabric keeps the surgical site environment optimal. We recommend compression socks as standard post-operative protocol for all plantar fascia surgeries at our practice.

Your Complete Plantar Fibroma Management Kit

Most Common Mistake: Aggressive Self-Treatment of Plantar Fibromas

Warning Signs: When Your Plantar Mass Needs Urgent Evaluation

Frequently Asked Questions About Plantar Fibromas

Can a plantar fibroma go away on its own without treatment?

Spontaneous resolution of plantar fibromas is extremely rare. Unlike some soft tissue cysts that can rupture and reabsorb, fibromas are composed of dense collagenous tissue that the body does not readily break down or remodel. The vast majority of untreated fibromas either remain stable in size or slowly enlarge over time. However, the symptoms associated with a fibroma can wax and wane depending on activity levels, footwear choices, and inflammatory status — a period of reduced symptoms doesn’t mean the fibroma is shrinking, just that conditions are temporarily more favorable.

Is a plantar fibroma the same as plantar fasciitis?

No, these are fundamentally different conditions despite both involving the plantar fascia. Plantar fasciitis is an overuse injury causing inflammation at the fascial heel attachment — it produces classic heel pain with first morning steps. A plantar fibroma is a benign growth within the fascia body itself — it creates a palpable arch lump with pain during direct pressure. Treatment approaches differ significantly: fasciitis responds to stretching and anti-inflammatory measures, while fibromas require accommodation-based offloading and potentially interventional treatments.

How successful is surgery for plantar fibroma removal?

Surgical success depends heavily on how you define it. If success means removing the visible mass, surgery achieves this nearly 100% of the time. However, if success means permanent resolution, the picture is more complex: simple local excision has a 60-100% recurrence rate, wide excision with margins reduces this to 20-40%, and complete fasciectomy achieves 10-25% recurrence but carries significant functional consequences including arch collapse. This is why comprehensive conservative management is recommended first — surgery should be a last resort after exhausting non-operative options.

Should I be worried that my plantar fibroma could be cancer?

Malignant transformation of a plantar fibroma is exceptionally rare — essentially a case-report-level event rather than a realistic clinical concern. However, other soft tissue tumors (including rare fibrosarcomas and synovial sarcomas) can occasionally present as plantar masses mimicking fibromas. Warning signs that warrant advanced imaging and possible biopsy include rapid growth, pain at rest, skin changes, fixation to deep structures, or size exceeding 5 cm. For typical presentations — a firm, slowly growing, mobile nodule in the arch — cancer concern is minimal.

Can I still exercise with a plantar fibroma?

Most patients with plantar fibromas can continue exercising with appropriate modifications. Low-impact activities like swimming, cycling, and elliptical training place minimal direct pressure on the arch and are generally well-tolerated. Running and high-impact activities may aggravate symptoms and should be performed with proper orthotic inserts in supportive shoes. Avoid exercises that involve barefoot weight-bearing on hard surfaces. The key principle is to protect the fibroma from direct pressure — if an activity reproduces your arch pain, modify your approach rather than pushing through it.

Visit Balance Foot & Ankle — Same-Day Appointments Available

Our podiatry team serves patients throughout Michigan including Howell, Brighton, and Bloomfield Hills. If you’re dealing with heel pain, ingrown toenails, or a foot injury, we have same-day appointment availability.

Sources & References

1. Young JR, Sternbach S, Willinger M, Hutchinson ID, Rosenbaum AJ. “The etiology, evaluation, and management of plantar fibromatosis.” Orthopedic Research and Reviews, 2019;11:1-7.
2. Veith NT, Tschernig T, Histing T, Madry H. “Plantar fibromatosis — topical review.” Foot and Ankle International, 2013;34(12):1742-1746.
3. Sammarco GJ, Mangone PG. “Classification and treatment of plantar fibromatosis.” Foot and Ankle International, 2000;21(7):563-569.
4. Bedi DG, Davidson DM. “Plantar fibromatosis: most common sonographic appearance and variations.” Journal of Clinical Ultrasound, 2001;29(9):499-505.
5. Knobloch K, Vogt PM. “High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis (Ledderhose’s disease).” BMC Research Notes, 2012;5:505.

Watch: Understanding Plantar Fibroma Treatment

Schedule Your Plantar Fibroma Evaluation

Related Arch & Foot Condition Guides

• Plantar Fasciitis Treatment Guide
• Custom Orthotics: Complete Guide
• Foot Arch Pain: Causes & Solutions
• Shockwave Therapy for Foot & Ankle
• Best Shoes for Arch Support
• All Podiatrist-Recommended Products

Affiliate Disclosure: This page contains affiliate links to products we recommend. Balance Foot & Ankle may earn a small commission at no additional cost to you. We only recommend products that Dr. Biernacki personally evaluates and uses in clinical practice. This content is for informational purposes only and does not replace professional medical evaluation.

Dr. Tom’s Recommended Products: See our clinically tested product recommendations for this condition. View Dr. Tom’s recommended products →

When to See a Podiatrist for a Plantar Fibroma

If you’ve noticed a firm lump in the arch of your foot that causes pain when walking or standing, a podiatrist can diagnose a plantar fibroma and discuss treatment options from orthotics to surgical excision. At Balance Foot & Ankle, we treat plantar fibromas at our Howell and Bloomfield Hills offices.

Learn About Our Foot Arch Treatment Options | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Espert M, Anderson MR, Baumhauer JF. “Current concepts review: plantar fibromatosis.” Foot & Ankle International. 2018;39(6):751-757.
2. Sammarco GJ, Mangone PG. “Classification and treatment of plantar fibromatosis.” Foot & Ankle International. 2000;21(7):563-569.
3. Young JR, Sternbach S, Willinger M, Hutchinson ID, Kittisomprayoonkul A. “The etiology, evaluation, and management of plantar fibromatosis.” Orthopedic Research and Reviews. 2019;11:1-7.

Dr. Tom’s Top 3 — The Premium Foot Pain Stack (2026)

If you only buy three things for foot pain, get these. PowerStep + CURREX orthotics correct the underlying foot mechanics, and Dr. Hoy’s pain gel delivers fast topical relief. This is the exact stack Dr. Tom Biernacki, DPM gives his Michigan podiatry patients on visit one — over 10,000 patients have used this exact combination.

What is Foot pain?

Foot pain is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.

Symptoms and warning signs

Common signs of foot pain include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.

Conservative treatment options

Most cases of foot pain respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including MLS laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.

When is surgery considered?

Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.

AAOS: Plantar Fibroma

Recovery timeline and prevention

Recovery from foot pain varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.